Accelerate to discover
Related topics
IVM-MS2: the most compact IntraVital Two-Photon microscope in the world
Apr 28, 2021
IVIM Technology, Inc. has released the most compact all-in-one intravital two-photon microscope. IVM-MS2 is the world's...
Cytek Spectral cytometers : taking science one step further with 200+ Publications
Apr 26, 2021
Cytek Aurora is helping researchers around the world take their science further. See how in the 200+ publications in...
Observe the movement of live cells that make up living tissue in vivo
Apr 8, 2021
IntraVital Microscopy is a technique that enables you to directly observe the movement of live cells that make up...
Unleash Your Illumina Sequencer with TELL-Seq Linked Reads
Mar 24, 2021
Sage Science distributes universal sequencing technology´s TELL-Seq linked-read NGS library prep kits used with very...
Preclinical lung imaging offers effective evaluation of drug candidates
Mar 1, 2021
The incidence of respiratory disease is increasing throughout the world, and the demand for safe, effective drugs to...
Curiox Laminar Wash technology to become a gold standard for TotalSeq Protocol.
Feb 15, 2021
Curiox Laminar Wash technology has been added as part of the official BioLegend TotalSeq Protocol. It makes processing...
Amnis CellStream's new software features - now better than ever
Feb 12, 2021
It's finally here, and better than ever - Amnis CellStream's Acquisition and Analysis Software update increases ease of...
Towards silent and distortion-free fMRI with Zero Echo Time MRI
Feb 9, 2021
By using fast imaging techniques capable of scanning large brain regions within short durations, continuous snapshots...
May 18, 2016
With the increasing need for new therapies for cancer, autoimmune disorders and Alzheimer’s disease, monoclonal antibodies are proving very successful due to their high affinity and specificity for their target antigens. In cancer, for example, their first use was as antagonists of oncogenic receptor tyrosine kinases, but today monoclonal antibodies have emerged as vehicles for the targeted delivery of potent chemotherapeutic agents and as powerful tools to manipulate anticancer immune responses. Currently,
more than 30 antibody therapeutics are marketed worldwide. Some analysts predict that, given the rate of current revenue growth and potential new approvals, the global market could reach $58 billion by 2016. In addition, there are hundreds of monoclonal antibody-based biologic drugs in various phases of clinical trials worldwide.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
